Misys chief Kilroy exits for biotech company Genus

Misys general counsel Tom Kilroy is leaving the software company to join listed biotechnology company Genus next month.


Kilroy moved into management last year when Misys named him as interim chief executive following the departure of incumbent Mike Lawrie left at the end of March (8 February 2012 ).The move also gave him a seat on the Misys board. He had been general counsel there since 2009, having joined from GE Healthcare.

Kilroy’s move follows the appointment of Misys president and chief operating office Nadeem Syed as CEO. Syed joined the company last year following its acquisition by Vista Equity Partners (20 February 2012 ).

In the role he led the company through the £1.3bn takeover by Vista, and was named in The Lawyer’s Hot 100 2013 (see video interview below).

Genus currently has an interim general counsel in the shape of Baker & McKenzie associate Ron Kirschner, who was appointed in March this year.

Kilroy, a prolific user of social media site Twitter, announced his move yesterday, adding that he was looking forward to moving to a “completely different sector”.

In a statement he said he was glad to have played a part in the transformation of Misys’s prospects.

”I’ve been enormously impressed by all the people I have met at Genus and I believe its values and its strategy position the business strongly for the future. This is an exciting time to join Genus and I look forward to becoming part of the team and helping to deliver Genus’s future success,” Kilroy said.

A spokesperson from Misys said the company had not yet begun its search for a new general counsel.


Tom Kilroy